AUS
NZ
UK
CA
USA
IND
British artificial intelligence start-up GenIP has unveiled its plans to list on London’s AIM market. The announcement follows the filing of a 'Schedule One' document with the London Stock Exchange for the proposed initial public offering (IPO).
GenIP, supported by growth company backer Tekcapital PLC (LSE:TEK), specializes in Generative AI (GenAI) analytic services. The company offers solutions that assist businesses, research institutions, and venture funds in evaluating and commercializing new technological discoveries. Among its services are AI-enhanced research reports and executive recruitment tailored for the technology sector.
GenIP’s client base includes notable entities such as Brazil’s National Nuclear Energy Commission (CNEN), Fundación Copec UC, and the University of Huddersfield.
Dr. Clifford Gross, executive chair of Tekcapital, expressed enthusiasm about GenIP’s forthcoming IPO. He highlighted that GenIP emerged from Tekcapital's technology incubator and has played a crucial role in commercializing various technological innovations through its Invention Evaluator and Vortechs platforms. These tools have helped transform ideas from conception to operational companies and listed spinouts.
Dr. Gross noted that with established commercial relationships and a successful launch of revenue-generating GenAI analytics services, GenIP is well-positioned for growth as an independent entity in the broader market.
Following the IPO, Tekcapital is anticipated to hold a 63% stake in GenIP. The IPO aims to raise approximately £1.5 million for the company. The board of GenIP will be led by Lord David Willetts, currently the chair of the UK Space Agency, and will include Dr. David Gann, former chair of the UK Atomic Energy Authority, as a non-executive director.
This move marks a significant milestone for GenIP as it prepares to expand its footprint in the AI industry, leveraging its strong foundation and established market presence.
